HC Wainwright & Co. Maintains Buy on Altimmune, Raises Price Target to $50

HC Wainwright & Co. analyst Patrick Trucchio maintains Altimmune (NASDAQ:ALT) with a Buy and raises the price target from $25 to $50.

byBenzinga Newsdesk

August 17, 2022

1 minute read

HC Wainwright & Co. analyst Patrick Trucchio maintains Altimmune (NASDAQ:ALT) with a Buy and raises the price target from $25 to $50.

Raymond James Maintains Outperform on Lumentum Holdings, Raises Price Target to $99

By Benzinga Newsdesk

Today, 7:44 AM

Raymond James analyst Simon Leopold maintains Lumentum Holdings (NASDAQ:LITE) with a Outperform and raises the price target from $96 to $99.

LITE

Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis

By Lara Goldstein

Today, 7:44 AM

Biotech psychedelics researcher and developer Silo Pharma Inc. (OTCQB: SILO) announced its topically-administered proprietary ketamine obtained a positive outcome in a recent preclinical study.

SILO

B of A Securities Downgrades Upstart Hldgs to Neutral, Lowers Price Target to $41

By Benzinga Newsdesk

Today, 7:44 AM

B of A Securities analyst Nat Schindler downgrades Upstart Hldgs (NASDAQ:UPST) from Buy to Neutral and lowers the price target from $255 to $41.

UPST

Dogecoin Daily: Crypto Reacts To Record Inflation Numbers, Co-Creator Recommends Reading Karl Marx

By Shivdeep Dhaliwal

Today, 7:44 AM

Dogecoin (CRYPTO: DOGE) traded nearly flat at $0.06 over 24 hours leading up to early Thursday morning. DOGE saw minimal movement while other major coins traded slightly in the green at press time. The global cryptocurrency market cap registered a 2.4% increase to $892.7 billion.

$DOGE

HC Wainwright & Co. Maintains Buy on Altimmune, Raises Price Target to $50

Related Posts

Raymond James Maintains Outperform on Lumentum Holdings, Raises Price Target to $99

Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis

B of A Securities Downgrades Upstart Hldgs to Neutral, Lowers Price Target to $41

Dogecoin Daily: Crypto Reacts To Record Inflation Numbers, Co-Creator Recommends Reading Karl Marx